Adult immunizations

Annals of Internal Medicine

Volumn 124, Issue 1 I, 1996, Pages 35-40

  Gardner, Pierce ^c   Eickhoff, Theodore ^c   Poland, Gregory A ^c   Gross, Peter ^c   Griffin, Marie ^c   LaForce, F Marc ^c   Schaffner, William ^a   Strikas, Raymond ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DIS CONTR AND PREV   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; HEPATITIS A VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; TYPHOID VACCINE;

CHICKENPOX; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HEPATITIS A; HUMAN; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; TYPHOID FEVER; VACCINATION;

EID: 0030032262     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-1_part_1-199601010-00007     Document Type: Review

References (34)

1. American College of Physicians Task Force on Adult Immunization and Infectious Diseases Society of America, Guide for Adult Immunization Philadelphia: American Coll Physicians; 1994
2. Kane MA. Perspectives on the control of hepatitis A by vaccination Vaccine 1992, 10(Suppl 1) S93-6.
3. Akriviadis EA, Redeker AG. Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med. 1989;110 838-9
4. Lemon SM, Shapiro CN. The value of immunization against hepatitis A Infect Agents Dis 1994;1:38-49.
5. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A seroepidemiology and risk groups in the USA Vaccine. 1992;10(Suppl 1) S59-62
6. Jilig W, Deinhardt F, Hilleman MR. Hepatitis A Vaccine In. Plotkin SA, Mortimer EA, eds. Vaccines Philadelphia: WB Saunders; 1994,583-96
7. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection against hepatitis A by an inactivated vaccine JAMA. 1994;271 1328-34
8. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children N Engl J Med 1992,327:453-7.
9. McMahon BJ, Beller M, Williams J, Schloss M, Snowball M, Tanttila H, et al. A program to control an outbreak of hepatitis A in Alaska using an inactivated hepatitis A vaccine [Abstract] In: Program and Abstracts - 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1994 H11
10. Green MS, Cohen D, Lerman Y, Sjogren M, Binn LN, Zur S, et al. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis. 1993,168: 740-3.
11. Wagner G, Lavanchy D, Darioli R, Pecoud A, Brulein V, Safary A, et al. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers. Vaccine. 1993;11:1027-32.
12. Kelley PW, Petruccelli BP, Stehr-Green P, Erickson RL, Mason CJ. The susceptibility of young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits JAMA 1991,2662724-9
13. Harris RE, Rhoades ER. Varicella pneumonia complicating pregnancy report of a case and review of the literature Obstet Gynecol. 1965,25.734-40
14. Morens DM, Bregman DJ, West CM, Greene MH, Mazur MH, Dolin R, et al. An outbreak of varicella-zoster virus infection among cancer patients Ann Intern Med 1980;93.414-9
15. Hope-Simpson RE. The nature of herpes zoster: a long term study and a new hypothesis. Proceedings of the Royal Society of Medicine 1965,58:9-20
16. White CJ, Kuter BJ, Hildebrand CS, Isganitis KL, Matthews H, Miller WJ, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents, results from clinical trials, 1987 to 1989 Pediatrics 1991;87 604-10
17. Gershon AA, Steinberg SP, LaRussa P, Ferrara A, Hammerschlag M, Gelb L. Immunization of healthy adults with live attenuated varicella vaccine J Infect Dis 1988,158.132-7
18. Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, et al. Live attenuated varicella vaccine. Efficacy trial in healthy children. N Engl J Med 1984;310.1409-15
19. Tsolia M, Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group J Pediatr 1990,116.184-9
20. Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DK, Neff BJ, et al. Oka/Merck varicella vaccine in healthy children final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 1991,9:643-7
21. Alter SJ, Hammond JA, McVey CJ, Myers MG. Susceptibility to varicellazoster virus among adults at high risk for exposure. Infect Control 1986,7 448-51.
22. Struewing JP, Hyams KC, Tueller JE, Gray GC. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. Am J Public Health 1993;83:1717-20
23. Gershon AA, Steinberg SP, LaRussa PS. Detection of antibody to varicella zoster virus using the latex agglutination assay. Clin Diag Virol 1994,2 271-8.
24. Gershon AA, Steinberg SP. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine N Engl J Med. 1989 320 892-7
25. Ryan CA, Hargrett-Bean NT, Blake PA. Salmonella typhi infections in the United States, 1975-1984. increasing role of foreign travel. Rev Infect Dis 1989;11 1-7
26. Centers for Disease Control and Prevention. Typhoid immunization - recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1994 43:1-7
27. Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever Lancet 1987,330:1165-9.
28. Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi A preliminary report N Engl J Med 1987,317: 1101-4.
29. Centers for Disease Control and Prevention. Influenza and pneumococral vaccination coverage levels among persons aged ≥65 years - United States 1973-1993 MMWR Morb Mortal Wkly Rep 1995;44:506-15
30. Centers for Disease Control and Prevention. Assessing adult vaccination status at age 50 years MMWR Morb Mortal Wkly Rep 1995;44 561-3.
31. Fedson DS. Adult immunization Summary of the National Vaccine Advisory Committee Report JAMA 1994;272 1133-7.
32. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community N Engl J Med 1994;331 778-84
33. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995,123:518-27
34. Nichol KU Lind A, Margolis KU Murdoch M, McFadden R, Hauge M, et al. The effectiveness of vaccination against influenza in healthy, working adults N Engl J Med 1995,333.889-93.